Financhill
Back

Inhibrx 10K Form

Buy
52

INBX
Inhibrx

Last Price:
20.48
Seasonality Move:
-23.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBX News And Ratings

See the #1 stock for the next 7 days that we like better than INBX

INBX Financial Statistics

Sales & Book Value

Annual Sales: $2.18M
Cash Flow: $-55.06M
Price / Cash Flow: 0
Annual Sales: $2.74
Price / Book: 7.66

Profitability

EPS (TTM): -4.25000
Net Income (TTM): $-188.67M
Gross Margin: --
Return on Equity: -660.05%
Return on Assets: -72.83%

Inhibrx Earnings Forecast

Key Inhibrx Financial Ratios

  • The Research & Development expenses have been 5,054.59% of Revenue.
  • The Interest Expense is -11.09% of Operating Income.
  • The Net Earning history of INBX is -6,661.93% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Inhibrx Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: INBX
Website: inhibrx.com

Debt

Debt-to-Equity Ratio: 1.59
Current Ratio: 10.16
Quick Ratio: 9.44

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBX Technical Analysis vs Fundamental Analysis

Buy
52
Inhibrx (INBX) is a Buy

Is Inhibrx a Buy or a Sell?

  • Inhibrx stock is rated a Buy
    The current Inhibrx [INBX] share price is $21.00. The Score for INBX is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.